Wellington Global Health Care Equity Fund is an actively managed global equity fund in healthcare with a track record going back to 2006. The management company is Wellington Management, one of the world's largest independent, privately owned asset managers, headquartered in Boston. It runs active equity, fixed income and multi-asset strategies and also acts as sub-adviser for many other fund companies.
Investment philosophy
The manager describes a long-term, value-oriented approach.
The managers
The fund is managed by Rebecca Sykes in Boston, who has managed it since 2022. She is a senior managing director and global sector analyst and leads Wellington's healthcare research team. She joined Wellington in 2007 from Goldman Sachs. She also manages Vanguard Health Care Fund, where she became sole manager in 2025, succeeding Wellington's chief executive Jean Hynes. She holds a bachelor's degree and an MBA from the Wharton School.
The portfolio
The portfolio holds more companies than comparable funds. Its centre of gravity is large pharmaceutical companies and medical technology, with North America as the largest region. Companies such as Eli Lilly, Merck, AstraZeneca, Intuitive Surgical and Danaher have recurred.
Sector Health Care Equities · 31 funds in the peer group. The number ranked and the date are stated per period. 12 of them converted to NOK.
11 of 22 funds ranked on a calculated return
#7/ 221 year
+13.76% NOK
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#10/ 223 years (ann.)
+8.02% NOK
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#14/ 225 years (ann.)
+5.72% NOK
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
Comparison basis
1 year
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
3 years (ann.)
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
5 years (ann.)
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.
Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.